Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. more
Time Frame | AMED | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.65% | -2.06% | -0.55% |
1-Month Return | -5.01% | -1.92% | 2.72% |
3-Month Return | -12.54% | -10.4% | 7.66% |
6-Month Return | -7.27% | -4.6% | 10.15% |
1-Year Return | -10.41% | 4.06% | 27.53% |
3-Year Return | -43.62% | 1.94% | 32.31% |
5-Year Return | -47.2% | 36.48% | 89.2% |
10-Year Return | 204.77% | 97.46% | 194.59% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.96B | 2.07B | 2.21B | 2.22B | 2.24B | [{"date":"2019-12-31","value":87.45,"profit":true},{"date":"2020-12-31","value":92.63,"profit":true},{"date":"2021-12-31","value":99,"profit":true},{"date":"2022-12-31","value":99.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.15B | 1.19B | 1.23B | 1.26B | 1.25B | [{"date":"2019-12-31","value":91.27,"profit":true},{"date":"2020-12-31","value":94.05,"profit":true},{"date":"2021-12-31","value":97.85,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.82,"profit":true}] |
Gross Profit | 805.30M | 886.15M | 980.76M | 962.77M | 990.87M | [{"date":"2019-12-31","value":81.27,"profit":true},{"date":"2020-12-31","value":89.43,"profit":true},{"date":"2021-12-31","value":98.98,"profit":true},{"date":"2022-12-31","value":97.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 41.18% | 42.78% | 44.30% | 43.31% | 44.31% | [{"date":"2019-12-31","value":92.94,"profit":true},{"date":"2020-12-31","value":96.55,"profit":true},{"date":"2021-12-31","value":99.97,"profit":true},{"date":"2022-12-31","value":97.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 626.35M | 662.73M | 728.84M | 778.99M | 834.48M | [{"date":"2019-12-31","value":75.06,"profit":true},{"date":"2020-12-31","value":79.42,"profit":true},{"date":"2021-12-31","value":87.34,"profit":true},{"date":"2022-12-31","value":93.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 177.47M | 219.27M | 251.91M | 180.77M | 156.39M | [{"date":"2019-12-31","value":70.45,"profit":true},{"date":"2020-12-31","value":87.04,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":71.76,"profit":true},{"date":"2023-12-31","value":62.08,"profit":true}] |
Total Non-Operating Income/Expense | (21.50M) | (19.20M) | 18.84M | (42.58M) | (143.07M) | [{"date":"2019-12-31","value":-114.11,"profit":false},{"date":"2020-12-31","value":-101.88,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-226,"profit":false},{"date":"2023-12-31","value":-759.39,"profit":false}] |
Pre-Tax Income | 170.41M | 210.82M | 280.23M | 160.24M | 39.62M | [{"date":"2019-12-31","value":60.81,"profit":true},{"date":"2020-12-31","value":75.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":57.18,"profit":true},{"date":"2023-12-31","value":14.14,"profit":true}] |
Income Taxes | 42.50M | 25.64M | 70.06M | 42.55M | 50.56M | [{"date":"2019-12-31","value":60.66,"profit":true},{"date":"2020-12-31","value":36.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":60.72,"profit":true},{"date":"2023-12-31","value":72.16,"profit":true}] |
Income After Taxes | 127.91M | 185.18M | 210.17M | 117.70M | (10.94M) | [{"date":"2019-12-31","value":60.86,"profit":true},{"date":"2020-12-31","value":88.11,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":56,"profit":true},{"date":"2023-12-31","value":-5.2,"profit":false}] |
Income From Continuous Operations | 127.91M | 185.18M | 210.17M | 117.70M | 1.59M | [{"date":"2019-12-31","value":60.86,"profit":true},{"date":"2020-12-31","value":88.11,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":56,"profit":true},{"date":"2023-12-31","value":0.76,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 126.83M | 183.61M | 209.07M | 118.61M | (9.75M) | [{"date":"2019-12-31","value":60.66,"profit":true},{"date":"2020-12-31","value":87.82,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":56.73,"profit":true},{"date":"2023-12-31","value":-4.66,"profit":false}] |
EPS (Diluted) | 4.41 | 6.12 | 5.94 | 5.01 | 4.29 | [{"date":"2019-12-31","value":72.06,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.06,"profit":true},{"date":"2022-12-31","value":81.86,"profit":true},{"date":"2023-12-31","value":70.1,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
AMED | |
---|---|
Cash Ratio | 0.51 |
Current Ratio | 1.19 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
AMED | |
---|---|
ROA (LTM) | 6.27% |
ROE (LTM) | 7.21% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
AMED | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.44 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.54 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
AMED | |
---|---|
Trailing PE | 33.88 |
Forward PE | 17.06 |
P/S (TTM) | 1.20 |
P/B | 2.44 |
Price/FCF | 27 |
EV/R | 1.30 |
EV/Ebitda | 13.35 |
PEG | 1.14 |
Amedisys Inc (AMED) share price today is $84.97
Yes, Indians can buy shares of Amedisys Inc (AMED) on Vested. To buy Amedisys Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AMED stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Amedisys Inc (AMED) via the Vested app. You can start investing in Amedisys Inc (AMED) with a minimum investment of $1.
You can invest in shares of Amedisys Inc (AMED) via Vested in three simple steps:
The 52-week high price of Amedisys Inc (AMED) is $98.95. The 52-week low price of Amedisys Inc (AMED) is $84.06.
The price-to-earnings (P/E) ratio of Amedisys Inc (AMED) is 33.877
The price-to-book (P/B) ratio of Amedisys Inc (AMED) is 2.44
The dividend yield of Amedisys Inc (AMED) is 0.00%
The market capitalization of Amedisys Inc (AMED) is $2.80B
The stock symbol (or ticker) of Amedisys Inc is AMED